A network meta-analysis of primary prophylaxis for invasive fungal infection in haematological patients.

L P LeonartF S ToninV L FerreiraS T S PenteadoA WiensF A MottaRoberto Pontarolo

Published in: Journal of clinical pharmacy and therapeutics (2017)

The results of our work support prophylaxis with antifungal agents as reducing the risk of IFI in haematological patients. Overall, the second-generation azoles were found to be the best option for preventing IFI in this population.

Keyphrases

end stage renal disease
newly diagnosed
chronic kidney disease
ejection fraction
peritoneal dialysis
prognostic factors
patient reported outcomes
candida albicans
patient reported
cell wall